Cargando…
The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study
BACKGROUND: The Saudi Food and Drug Authority (SFDA) classified pregabalin as a controlled substance in 2018; however, whether this policy change has affected pregabalin use is unclear. This study examined the trends in pregabalin prescriptions before and after the SFDA restriction. In addition, the...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665920/ https://www.ncbi.nlm.nih.gov/pubmed/38028223 http://dx.doi.org/10.1016/j.jsps.2023.101851 |